Thromboxane

Thromboxane is a potent lipid mediator and an important component of the hemostatic process in mammals. It is produced from arachidonic acid via the enzyme thromboxane synthase and is derived from platelet activation. It acts mainly through thromboxane receptors to cause the constriction of blood vessels, platelet aggregation, bronchoconstriction, and leukotriene production. The importance of Thromboxane is primarily in its role as a vasoconstrictor and its ability to stimulate platelet aggregation. Due to its potent vasoconstrictive properties, Thromboxane is important in the regulation of blood pressure as well as preventing excessive bleeding. It is also involved in inflammatory responses, including the stimulation of bronchoconstriction. Thromboxane is also useful in research, as its presence can be used to diagnose certain disorders such as vasculitis or thrombophilia. By understanding the roles of Thromboxane in physiological processes, researchers hope to gain insight into the underlying causes of these diseases, and to find potential treatments.

← Journal of Thrombosis and treatments

Related Articles

1 journal(s) found

Thrombosis and treatments

ISSN: Coming Soon
Type: Open Access Journal
Editor: Max Saito, Federal University of Rio Grande do Sul
Journal of Thrombosis and treatments mainly concentrates on the leading science concerned to the important therapeutic complications of thrombosis, bleeding disorders, and vascular biology through the diffusion and transfer of science, and suggestions within the universal research community.